Zoetis Inc. Disposal Group, Including Discontinued Operation, Liabilities
Zoetis Inc. (ZTS) had Disposal Group, Including Discontinued Operation, Liabilities of $26.00 million as of 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation · last filed 2024-11-04
- 2024-09-30: Disposal Group, Including Discontinued Operation, Liabilities $26.00M.
- 2024-06-30: Disposal Group, Including Discontinued Operation, Liabilities $25.00M.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Liabilities $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities |
|---|---|
| 2024-09-30 | $26.00M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $25.00M 10-Q · filed 2024-08-06 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |